How to make opinion leaders and influence people.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

9 citing papers in PubMed.

1. Pharmaceutical industry use of key opinion leaders to market prescription opioids: A review of internal industry documents.Exploratory research in clinical and social pharmacy · 2024
   Review
2. Undisclosed financial conflicts of interest in DSM-5-TR: cross sectional analysis.BMJ (Clinical research ed.) · 2024
   Article
3. Cross-sectional analysis of pharmaceutical payments to Japanese board-certified gastroenterologists between 2016 and 2019.BMJ open · 2023
   Article
4. A pilot study of a mixed-method approach to design an ED-based peer mHealth referral tool for HIV/HCV and opioid overdose prevention services.Drug and alcohol dependence · 2022
   Article
5. Pharmaceutical Sales Representatives in the United States and China: The Need for Professional Public Space.Health care analysis : HCA : journal of health philosophy and policy · 2022
   Article
6. Sunshine on KOLs: assessment of the nature, extent and evolution of financial ties between the leaders of professional medical associations and the pharmaceutical industry in France from 2014 to 2019: a retrospective study.BMJ open · 2022
   Article
7. Association Between Conflicts of Interest and Authors' Positions on Harms of Varenicline: a Cross-Sectional Analysis.Journal of general internal medicine · 2022
   Article
8. GPs' perceptions of their relationship with the pharmaceutical industry: a qualitative study.BJGP open · 2021
   Article
9. Medicines Information and the Regulation of the Promotion of Pharmaceuticals.Science and engineering ethics · 2019
   Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.